1. Home
  2. Analysis
  3. Pregabalin
  4. Nail-abnormalities

Pregabalin and Nail abnormalities - a phase IV clinical study of FDA data

Summary:

Nail abnormalities is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are male, 60+ old, also take Humira, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Nail abnormalities when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Nail abnormalities?

Nail abnormalities (abnormal nail) is found to be associated with 210 drugs and 652 conditions by eHealthMe. Check the latest studies of Nail abnormalities.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 42 people (0.06%) have Nail abnormalities.

Could Pregabalin cause Nail abnormalities?

Among these 42 people:

What is the gender of people who have Nail abnormalities when taking Pregabalin? *

  • female: 34.21 %
  • male: 65.79 %

What is the age of people who have Nail abnormalities when taking Pregabalin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 2.78 %
  • 50-59: 0.0 %
  • 60+: 97.22 %

What are other drugs people take besides Pregabalin? *

  1. Lyrica: 24 people, 57.14%
  2. Stelara: 24 people, 57.14%
  3. Humira: 24 people, 57.14%
  4. Enbrel: 23 people, 54.76%
  5. Arava: 23 people, 54.76%
  6. Taltz: 23 people, 54.76%
  7. Simponi: 23 people, 54.76%
  8. Xeljanz: 22 people, 52.38%
  9. Amitriptyline Hydrochloride: 22 people, 52.38%
  10. Cosentyx: 21 people, 50.00%

What are other side effects people have besides Nail abnormalities? *

  1. Nausea (feeling of having an urge to vomit): 37 people, 88.10%
  2. Gait Disturbance: 25 people, 59.52%
  3. Weight Increased: 25 people, 59.52%
  4. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 25 people, 59.52%
  5. Psoriasis (immune-mediated disease that affects the skin): 24 people, 57.14%
  6. Glomerular Filtration Rate Decreased: 24 people, 57.14%
  7. Lipids Increased (excess lipid in body): 24 people, 57.14%
  8. Swelling: 24 people, 57.14%
  9. Carbon Dioxide Abnormal: 24 people, 57.14%
  10. Alanine Aminotransferase Increased: 24 people, 57.14%

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 25 people, 59.52%
  2. Swelling: 12 people, 28.57%
  3. Neuropathy Peripheral (surface nerve damage): 12 people, 28.57%
  4. Diarrhea: 12 people, 28.57%
  5. Urethral Cancer: 10 people, 23.81%
  6. Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 10 people, 23.81%
  7. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 4.76%
  8. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 2 people, 4.76%
  9. Iron Deficiency: 2 people, 4.76%
  10. Colon Cancer: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Nail abnormalities?

- Check whether Nail abnormalities is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Nail abnormalities treatments and more:

How severe was Nail abnormalities and when was it recovered:

Expand to all the drugs that have ingredients of pregabalin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nail abnormalities:

Browse all the conditions that are associated with Nail abnormalities:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.